Uploaded April 2024 | Updated September 2026, 2 weeks ago
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:22 Can patients with extremely high PSA's still achieve remission?
3:34 Do extremely high PSA's always correlate with aggressive disease?
4:52 What is monitoring like for a patient following intensive treatment for high PSA cancer?
6:55 Is triple therapy required for a patient with a PSA of over 1,000?
7:29 How rare is it for a patient with a PSA over 1,000 to achieve remission?
8:23 What are the options for those patients who don't achieve remission?
10:42 Is extremely high PSA cancer inherently more urgent?
12:16 What options are there if Pluvicto fails to control the growth of the disease?
13:12 Is Xofigo often used in combination on oligometastatic patients?
14:03 Can immune treatments like Provenge be used in combination therapy?
15:38 How effective are PARP inhibitors?
16:31 Alex's conclusions
17:57 If you need more help
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:22 Can patients with extremely high PSA's still achieve remission?
3:34 Do extremely high PSA's always correlate with aggressive disease?
4:52 What is monitoring like for a patient following intensive treatment for high PSA cancer?
6:55 Is triple therapy required for a patient with a PSA of over 1,000?
7:29 How rare is it for a patient with a PSA over 1,000 to achieve remission?
8:23 What are the options for those patients who don't achieve remission?
10:42 Is extremely high PSA cancer inherently more urgent?
12:16 What options are there if Pluvicto fails to control the growth of the disease?
13:12 Is Xofigo often used in combination on oligometastatic patients?
14:03 Can immune treatments like Provenge be used in combination therapy?
15:38 How effective are PARP inhibitors?
16:31 Alex's conclusions
17:57 If you need more help
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
